symmetric dimethylarginine has been researched along with probucol in 1 studies
| Studies (symmetric dimethylarginine) | Trials (symmetric dimethylarginine) | Recent Studies (post-2010) (symmetric dimethylarginine) | Studies (probucol) | Trials (probucol) | Recent Studies (post-2010) (probucol) |
|---|---|---|---|---|---|
| 428 | 27 | 314 | 1,488 | 174 | 317 |
| Protein | Taxonomy | symmetric dimethylarginine (IC50) | probucol (IC50) |
|---|---|---|---|
| NAD-dependent protein deacylase sirtuin-5, mitochondrial | Homo sapiens (human) | 1.6 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, HW; Jiang, JL; Li Ns, NS; Li, YJ | 1 |
1 other study(ies) available for symmetric dimethylarginine and probucol
| Article | Year |
|---|---|
Probucol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level.
Topics: Animals; Aorta, Thoracic; Arginine; Endothelium, Vascular; Enzyme Inhibitors; Lipoproteins, LDL; Male; Malondialdehyde; Muscle, Smooth, Vascular; Nitric Oxide Synthase; Probucol; Rats; Rats, Sprague-Dawley; Vasodilation | 2002 |